Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abrysvo
Pharma
Sanofi has already produced as much Beyfortus as it sold in 2024
One day before the potential FDA approval of an RSV rival from Merck, Sanofi has revealed an aggressive supply effort for its blockbuster Beyfortus.
Kevin Dunleavy
Jun 9, 2025 11:14am
ACIP broadens guidance for RSV vaccines from GSK, Pfizer
Apr 17, 2025 11:04am
GSK, Pfizer end RSV patent feud amid vaccine market uncertainty
Apr 4, 2025 10:55am
FDA requires Pfizer, GSK to add new warning label on RSV shots
Jan 8, 2025 11:57am
GSK's Arexvy shows promise in younger adults
Oct 24, 2024 10:32am
FDA approves Pfizer's RSV shot Abrysvo for all at-risk adults
Oct 23, 2024 11:11am
